Medtronic, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 117   

Articles published

MDT 62.54 -0.80 (-1.26%)
price chart
Medtronic and Covidien are likely to renegotiate purchase terms: report
Medtronic Inc. will likely seek changes to the terms of its Covidien acquisition after the Treasury Department introduced regulations taking aim at tax inversions, Reuters reports.
DEALTALK-RPT-New US tax rules may lead Medtronic to redo inversion deal  Reuters
Dealpolitik: How New Inversion Rules Affect Medtronic's Deal With Covidien  Wall Street Journal (blog)
Related articles »  
Medtronic May Be The Biggest Loser In The Tax Inversion Race After New Tax ...
Medtronic, Inc. (MDT) may halt plans to shift its US tax domicile to Ireland through a $43 billion acquisition deal with Covidien plc (COV) due to new tax rules issued by the US Treasury Department Monday.
New US tax rules chill 'inversion' deal-making; shares dive  Daily Mail
Administration moves to discourage corporate 'inversions'  McClatchy Washington Bureau
Related articles »  
Tighter U.S. tax rules could change the math in Medtronic's Covidien deal (Video)
Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien Plc for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages.
3 Reasons Medtronic Inc.'s Stock Could Fall
Medtronic (NYSE: MDT ) posted solid first-quarter earnings last month -- revenue climbed 5% year over year to $4.27 billion, while non-generally accepted accounting principles diluted earnings per share rose 6% to $0.93.
Medtronic, Inc. (NYSE:MDT) To Reimburse Top Executives, Directors For ...  WallStreetPR
Related articles »  
Treasury's anti-inversion rules could target Medtronic
Medtronic is one of several U.S. companies this year to announce inversion strategies after merging with foreign companies, including Miami-based Burger King Worldwide Inc.'s plans to merge with Canada-based Tim Hortons Inc. These deals have raised ...
BofA/Merrill Lynch Reinstates Medtronic, Inc. (MDT) at Buy
BofA/Merrill Lynch reinstates coverage on Medtronic, Inc. (NYSE: MDT) with a Buy rating and a price target of $75, citing a strong risk/reward.
Medtronic's "Overweight" Rating Reiterated at Morgan Stanley (MDT)  Watch List News (press release)
Medtronic Target of Unusually Large Options Trading (MDT)  Intercooler
Related articles »  
3 Reasons Medtronic Inc. Stock Could Rise
Last month, Medtronic's (NYSE: MDT ) first-quarter earnings topped consensus estimates on the top and bottom lines, as revenue rose 5% year over year to $4.27 billion and non-GAAP diluted earnings climbed 6% to $0.93 per share.
Ex-Dividend Reminder: ClubCorp Holdings, Bristol-Myers Squibb and Medtronic
Looking at the universe of stocks we cover at Dividend Channel, on 10/1/14, ClubCorp Holdings Inc (NYSE: MYCC), Bristol-Myers Squibb Co.
Medtronic Extends Title Sponsorship of Twin Cities Marathon Through 2020
MINNEAPOLIS - Sept. 29, 2014 -Medtronic and Twin Cities In Motion, the organizers of the Medtronic Twin Cities Marathon, today announced a five-year, $2.5 million agreement that will keep Medtronic as the title sponsor of the Twin Cities Marathon and ...
Market Update (NYSE:MDT): Medtronic Extends Title Sponsorship of Twin Cities ...  Jutia Group
Stocks to Keep Your Eyes on - Medtronic, Inc. (NYSE:MDT), iShares S&P ...  Techsonian (press release)
Related articles »  
Form 8.3 - Medtronic Inc
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future ...